People

Dr Sarah Diver

Academic Clinical Lecturer

Profile

Academic Clinical Lecturer in Professor Brightling's research team at the Institute for Lung Health NIHR Respiratory BRC Glenfield Hospital.

Research

Research interests focus on airway inflammation and the association between inflammation and airway microbial composition in airways disease, in particular severe asthma. 

Publications

(0) Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Respir Med. 2021 Jul 9;S2213-2600(21)00226-5. doi: 10.1016/S2213-2600(21)00226-5.

The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study. Lancet Respir Med. 2021 May 7;S2213-2600(21)00004-7. doi: 10.1016/S2213-2600(21)00004-7.

Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline. Eur Respir J. 2020 Jan 2;55(1):1900588. doi: 10.1183/13993003.00588-2019. Print 2020 Jan

Sputum microbiomic clustering in asthma and chronic obstructive pulmonary disease reveals a Haemophilus-predominant subgroup. Allergy. 2020 Apr;75(4):808-817. doi: 10.1111/all.14058. Epub 2019 Oct 21.

Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles. J Allergy Clin Immunol. 2018 Jun;141(6):2027-2036.e12. doi: 10.1016/j.jaci.2018.04.013. Epub 2018 Apr 28.

Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma. Eur Respir J. 2019 Nov 14;54(5):1900930. doi: 10.1183/13993003.00930-2019. Print 2019 Nov.

Multi-omics links IL-6 trans-signalling with neutrophil extracellular trap formation and Haemophilus infection in COPD. Eur Respir J. 2021 Mar 25;2003312. doi: 10.1183/13993003.03312-2020. Online ahead of print.

Mepolizumab does not alter the blood basophil count in severe asthma. Allergy. 2019 Dec;74(12):2488-2490. doi: 10.1111/all.13879. Epub 2019 Jun 28.

CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma. Respir Res. 2020 Oct 13;21(1):265. doi: 10.1186/s12931-020-01513-x

ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions. Eur Respir J. 2019 Sep 28;54(3):1900900. doi: 10.1183/13993003.00900-2019. Print 2019 Sep.

Supervision

NA

Teaching

Completed postgraduate certificate in Medical Education, module 1, with distinction (Edge Hill University) in April 2015 and has ongoing involvement in postgraduate clinical medicine teaching at the Glenfield Hospital. 

Also has experience in facilitating undergraduate practical examinations for Year 3 Medical students at University of Leicester. 

In future, I hope to contribute to postgraduate teaching for MSc programs in Infection & Immunity and Chronic Disease & Inflammation. 

Press and media

NA
Back to top
arrow-downarrow-down-3arrow-down-2arrow-down-4arrow-leftarrow-left-3arrow-left-2arrow-leftarrow-left-4arrow-rightarrow-right-3arrow-right-2arrow-right-4arrow-uparrow-up-3arrow-up-2arrow-up-4book-2bookbuildingscalendar-2calendarcirclecrosscross-2facebookfat-l-1fat-l-2filtershead-2headinstagraminstagraminstagramlinkedinlinkedinmenuMENUMenu Arrowminusminusrotator-pausec pausepinrotator-playplayc playplussearchsnapchatsnapchatthin-l-1thin-l-2ticktweettwittertwittertwitterwechatweiboweiboyoutubeyoutube